CTLA4 and rheumatoid arthritis: Emerging evidence supports abatacept [CTL-associated antigen-4 (CTLA-4)–Ig] for intercepting pre-RA stages by modulating T cell costimulation, demonstrating reduced progression from autoantibody-positive at-risk states to clinical RA [122].